USANA Health Sciences, Inc.

Greetings. Welcome to USANA Health Sciences' fourth quarter and fiscal year 2025 earnings call. At this time, all participants will be in listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. Please note this conference is being recorded. At this time, I'll now turn the conference over to Andrew Masuda, Director of Investor Relations. Thank you, Andrew. You may now begin.

Thanks, Robin. Good morning, everyone. We appreciate you joining us to review our fourth quarter and fiscal year 2025 results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events, or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest, our Chief Financial Officer, Doug Hecking, our Chief Commercial Officer, Brett Neidig, our Chief Operating Officer, Walter Note, as well as other executives. Yesterday, after the market closed, we announced our fourth quarter and fiscal year 2025 results and posted our management commentary documents on the company's website. We'll now hear brief remarks from Kevin and Doug before opening the call for questions.

Thank you, Andrew, and good morning, everyone. As we sharpen our strategic focus and position the company for renewed and sustainable growth, I'm honored to return as Chief Executive Officer while continuing to serve as Chairman of the Board. I appreciate the Board's confidence in my leadership and its commitment to ensuring continual stability and disciplined execution during this next phase of growth. As I reassume the role of CEO, I do so with a deep understanding of USANA's strengths and a clear view of the opportunities ahead. with the fruition of our strategic plans that we will execute. Having spent more than three decades at this company, including eight years as CEO, I've seen firsthand the power of our science-based products, the dedication of our employees, and the resilience of our sales force across the world. These elements form the core of USANA's competitive advantage and establish a solid foundation for the long-term value creation that we intend to deliver. During my previous tenure, USANA expanded its international footprint, strengthened operational capabilities, and achieved record financial results. While this external environment continues to evolve, our strategic pillars remain consistent. Scientific excellence at the center of product innovation, operational discipline and cost efficiency, a high-performing aligned global sales force, and a culture rooted in integrity, resilience, and execution. Over the past several weeks, I've engaged in extensive discussions with our leadership team as well as our brand partners. These conversations reinforce that USANA remains well positioned with strong underlying fundamentals and meaningful opportunities for growth across multiple markets and channels. However, the clear message is that we must move with greater speed, focus, relevancy, and precision. As we look ahead, our priorities are straightforward. First, strengthen USANA's global brand positioning by delivering science-backed nutrition through an omni-channel platform and evolving the company's identity from a legacy direct selling business to a modern science-driven nutritional products company. Enhance the customer and brand partner experience to drive retention, loyalty, and long-term brand equity. Third, reinvigorate global sales momentum through enhanced field support, market-specific strategies, and strengthened leadership engagement. Fourth, advance our product innovation pipeline by leveraging our world-class research and science teams to deliver differentiated offerings. Fifth, improve operational efficiencies across the organization through disciplined cost management and streamlined processes. And sixth, execute with accountability at every level of the business, ensuring our actions translate into measurable, sustainable results. We are committed to delivering shareholder value by focusing on these top priorities. Importantly, our consolidated net sales outlook for fiscal 2026 is for growth of 4% at the midpoint, reflecting confidence in our strategy and our ability to execute. We will also remain focused on long-term strategic execution, not short-term optimization, as we strengthen the company for its next chapter of growth. Our fiscal 2026 operating strategy entails the following. First, expand our omnichannel reach by leveraging USANA's strong nutrition foundation and diversifying distribution channels to access a larger global base of health-conscious consumers and strengthen brand relevance. Second, advance product innovation through refreshed branding, alignment with modern consumer usage behaviors, and robust pipeline for upgraded and new products launching globally in 2026. Third, accelerate technology modernization by adopting best-in-practice third-party platforms to improve customer experience, enable scalable growth, and drive long-term IT and operational efficiencies. Fourth, drive highest growth through continued direct-to-consumer expansion, new channel and product launches, and entering into additional markets. We're also leveraging USANA's capabilities to improve margins, including transitioning to in-house manufacturing to increase speed, efficiency, and reduce costs. Fifth, scale RISE Wellness performance by building on the strong recent momentum, expanding the RISE bar footprint, and accelerating protein pots distribution, particularly within major retailers and within club retail channels. USANA's mission, Culture and people have always been at the heart of our success. As we embark on this transition, I am confident in our direction and energized by the opportunities ahead. Together, with clarity, discipline, and a shared vision, we will position USANA to deliver stronger performance and create enduring value for all stakeholders. With that, I'll now ask Doug to provide additional color on our fiscal 2026 outlook.